Meta-analysis of medical cannabis outcomes and associations with cancer
Abstract Background: Growing bodies of evidence suggest that cannabis may play a significant role in both oncological palliative care and…
Immuno-oncology
In silico pan-cancer analysis of VRAC subunits and their prognostic roles in human cancers
Abstract The study focuses on the VRAC channel and its significant roles in cancer development. It addresses a research gap…
IMPlications of IMP2 in RNA Biology and Disease
Abstract Insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) is an RNA-binding protein that positively regulates m6A-modified RNAs involved in…
Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers
Keywords: AUC, area under the curve, CCLE, cancer cell line encyclopedia, HR, hazard ratio, ROC, receiver operating characteristic, SHCBP1, Shc…
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
Abstract The suppressor of cytokine signaling (SOCS) family contains eight members, including SOCS1–7 and CIS, and SOCS3 has been shown…
MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
Keywords: MXD3, Immuno-oncology, Immunotherapy, Chemotherapy, Gene expression profiling, Immune-cell infiltration, T-cell exclusion, Genetic and epigenetic alterations Authors: Szu-Yuan Wu, Kuan-Chou…
Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Abstract Healthcare is undergoing a transformation, and it is imperative to leverage new technologies to generate new data and support…
The Cancer Omics Atlas: an integrative resource for cancer omics annotations
Abstract Background: The Cancer Genome Atlas (TCGA) is an important data resource for cancer biologists and oncologists. However, a lack…